Anna Ostropolets MD, PhD

Adjunct Assistant Professor of Biomedical Informatics
LinkedInEmail
Anna Ostropolets is Associate Director at Janssen Research and Development, a Johnson & Johnson Company, and Adjunct Assistant Professor of Biomedical Informatics at Columbia University. She works on the methods to advance observational research for medical products safety. She is a long-standing OHDSI collaborator who designs, builds and disseminates the framework, approaches and tools for minimizing bias in observational research with a specific focus on patient phenotyping. Some notable examples include Phoebe, an approach for comprehensive code selection, and KEEPER, an alternative for chart review.

Anna has been a member of the OHDSI Vocabulary Team since 2016, designing and engineering ontologies for the community (RxNorm Extension and ATC-RxNorm joint hierarchy). Since 2022 she is leading OHDSI Vocabulary improvement initiative focused on improving quality, fit-for-use and transparency of the OHDSI Standardized Vocabularies.

Anna received her PhD in biomedical informatics at Columbia University, and she received her medical degree and completed her residency in Kharkiv National Medical University. Her Columbia dissertation, Generating Reliable and Responsive Observational Evidence: Reducing Pre-analysis Bias, received the AMIA 2023 Edward H. Shortliffe Doctoral Dissertation Honorable Mention. Before joining Janssen, she worked as Director, Head of Innovation Lab in Odysseus Data Services coordinating business intelligence initiative for harmonization and visualization of real-world data.